Literature DB >> 7541197

Growth stimulation by transfection of intestinal epithelial cells with an antisense insulin-like growth factor binding protein-2 construct.

M R Corkins1, J A Vanderhoof, D H Slentz, R G MacDonald, J H Park.   

Abstract

IEC-6 cells, an intestinal epithelial cell line, produce insulin-like growth factor (IGF)-II and IGF-binding protein-2 (IGFBP-2). Exogenous IGFs stimulate and IGFBP-2 attenuates DNA synthesis. To investigate whether endogenously secreted IGFBP-2 inhibits proliferation, IEC-6 cells were transfected with a full-length rat IGFBP-2 cDNA antisense expression construct. The steady-state level of IGFBP-2 mRNA decreased by 54% in the antisense cDNA-transfected cells (denoted revBP2) compared with vector-transfected controls. Moreover, revBP2 cells secreted less IGFBP-2 than controls (maximally a 68% decrease). In serum-containing medium, revBP2 cells exhibited a 35% increase in log-phase proliferation rate and growth-arrested at a maximum density 14% higher than controls. We conclude that endogenous IGFBP-2 inhibits proliferation of IEC-6 cells, probably by sequestering IGFs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7541197     DOI: 10.1006/bbrc.1995.1870

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

Review 1.  Genetics, chemistry, and function of the IGF/IGFBP system.

Authors:  P F Collett-Solberg; P Cohen
Journal:  Endocrine       Date:  2000-04       Impact factor: 3.633

2.  IGFBP-2 - taking the lead in growth, metabolism and cancer.

Authors:  Steven W Yau; Walid J Azar; Matthew A Sabin; George A Werther; Vincenzo C Russo
Journal:  J Cell Commun Signal       Date:  2015-01-25       Impact factor: 5.782

3.  Insulin-like growth factor binding protein 7 mediates glioma cell growth and migration.

Authors:  Wei Jiang; Cunli Xiang; Simona Cazacu; Chaya Brodie; Tom Mikkelsen
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

4.  Activation-dependent expression of the insulin-like growth factor binding protein-2 in human lymphocytes.

Authors:  J L Föll; L Dannecker; C Zehrer; S Hettmer; J Berger; M Elmlinger; D Niethammer; M B Ranke; G E Dannecker
Journal:  Immunology       Date:  1998-06       Impact factor: 7.397

Review 5.  Insulin-like growth factor system in cancer: novel targeted therapies.

Authors:  Varsha P Brahmkhatri; Chinmayi Prasanna; Hanudatta S Atreya
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.